A controlled study of vitrectomy for diabetic macular edema

PURPOSE: To compare eyes that underwent surgery with untreated fellow eyes to assess the efficacy of vitrectomy for diabetic macular edema. METHODS: In a nonrandomized clinical trial, seven adult patients with mean age of 53 years (range 42 to 64) and the same degree and duration of diabetic macular edema in both eyes were followed up for more than 5 months after unilateral vitrectomy. The treated eye was selected at random, but if visual disparity between the both eyes was more than 3 lines, we operated on the worse side. We compared the preoperative and postoperative foveal thicknesses (the distance between the inner retinal surface and retinal pigment epithelium) and the best-corrected visual acuity by a certified examiner with those of the untreated fellow eye. RESULTS: In the seven eyes that underwent surgery, the foveal thickness decreased by an average of 622 to 269 microm (P =.027, Wilcoxon signed-rank test). In the fellow eyes, the average decrease in foveal thickness was from 617 to 546 microm (P =.176, Wilcoxon signed-rank test). The best-corrected postoperative visual acuity in the eyes that underwent surgery improved more than 2 lines in four eyes (57%) and remained the same in three eyes (43%). In the fellow eyes, it improved more than 2 lines in one eye (14%), remained the same in three eyes (43%), and decreased more than 2 lines in three eyes (43%). CONCLUSION: In eyes with diabetic macular edema that underwent surgery, the foveal thickness significantly decreased after vitrectomy. Vitrectomy may be effective for treating diabetic macular edema.     

Contrast sensitivity in amblyopia: the fellow eye of untreated and successfully treated amblyopes.

PURPOSE: We sought to investigate contrast sensitivity on the fellow eyes of amblyopic and successfully treated amblyopic subjects. METHODS: Contrast sensitivity was tested monocularly on both eyes of 48 amblyopic patients (mean age, 11.51 years) and of 22 successfully treated amblyopic subjects (visual acuity 20/20 in each eye; mean age, 11.22 years). Inclusion criteria were visual acuity in the amblyopic eye 20/40 or better (mild amblyopia) and 20/20 or better in the fellow eye, steady fixation, no signs of congenital, latent or manifest/latent nystagmus on clinical examination. Twenty normal subjects (20 eyes) were used as age-matched controls. RESULTS: Contrast sensitivity functions from the fellow eye of the 48 amblyopic patients, even those who had never been treated with occlusion therapy before, were significantly decreased (P < 0.001) compared with control subjects. Both the previously amblyopic and the fellow eye of the 22 "cured" amblyopic subjects demonstrated significantly lower values (P < 0.001) compared with control patients. CONCLUSIONS: We suggest that the nonamblyopic, "normal" eye of amblyopic patients behaves abnormally when evaluated for contrast sensitivity functions. Neither the previously amblyopic nor the fellow eyes of successfully treated subjects were comparable with controls. Occlusion therapy may not be implicated for depressed contrast sensitivity of the fellow eye in amblyopia. The assessment of contrast sensitivity can provide important information on the visual function and the influence of occlusion therapy in amblyopia.     

Radioactive plaque therapy for metastatic choroidal carcinoma

PURPOSE: To describe the outcome of radioactive episcleral plaque therapy for treatment of metastatic carcinoma to the choroid. DESIGN: Retrospective, noncomparative case series. PARTICIPANTS: Five patients (six eyes) with carcinoma metastatic to the choroid. METHODS: Retrospective review of the clinical records of five patients (six eyes) who underwent radioactive episcleral plaque therapy for choroidal metastases. MAIN OUTCOME MEASURES: Tumor height, visual acuity, radiation optic neuropathy, and radiation retinopathy. RESULTS: Radioactive episcleral plaque therapy resulted in shrinkage of the treated tumors and resolution of subretinal fluid in all eyes. After plaque treatment, best-corrected visual acuity was maintained within two lines of initial visual acuity for two eyes, decreased more than two lines for one eye, and improved more than two lines in three eyes. The treatment was well tolerated and there was no acute toxicity. Late complications included optic nerve atrophy (at 2 years) with proliferative radiation retinopathy (at 3 years) in one eye and optic atrophy (at 6 months) in another eye that had received prior external beam therapy. CONCLUSIONS: In carefully selected cases, radioactive episcleral plaque therapy appears to be an effective and reasonable treatment for carcinoma metastatic to the choroid.     

Argon laser photocoagulation treatment of diabetic cystoid maculopathy

Forty-one patients with diabetic cystoid macular edema were treated with argon laser photocoagulation and followed for a mean period of 22 months. The fellow eye was held as control. In the treated group (33 eyes), 6 had an improvement in visual acuity (greater than 2 lines), 19 had visual acuity which remained the same (+/- 1 line), and 8 had a decrease in visual acuity (more than 2 lines). In the control group (33 eyes untreated), 18 had a visual acuity which remained the same, one had an improvement in visual acuity (greater than 2 lines) and 14 had a decrease (greater than 2 lines) in visual acuity. The control eyes of 14 patients were treated because of significant reduction in visual acuity. Although the general tendency toward stabilization in the treated group and toward deterioration in the untreated group was definitely observed, statistical evaluation did not show a significant difference between the 2 groups. Occasionally, patients with cystoid in the control eye cleared spontaneously without treatment.     

Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation.

Twenty-one patients with symmetric nonproliferative retinopathy who underwent extracapsular cataract extraction and intraocular lens implantation were followed up postoperatively for an average (+/- standard deviation) of 18 +/- 7 months to determine the incidence of progression of diabetic retinopathy, the final visual acuity, and factors predictive of progression of retinopathy and final visual acuity. Progression of retinopathy, defined as the development of clinically significant macular edema, an increase in intraretinal hemorrhages or hard exudate, or the development of proliferative diabetic retinopathy, was assessed in both eyes of 19 patients; in two remaining patients, dense preoperative cataract in the fellow eye precluded comparison of retinopathy progression in the operated-on eye to progression in the fellow eye. Overall, retinopathy progressed in 14 of 19 operated-on eyes (74%). Cataract extraction was highly associated with asymmetric progression of nonproliferative retinopathy; it progressed only in the operated-on eye in seven of 19 patients (37%), but in no patients did progression occur in the fellow eye alone (P = .0078). Women had a significantly increased risk of progression of retinopathy in the operated-on eye compared to men (P = .005). Visual acuity improved in 19 of 21 operated-on eyes (86%); however, only 11 eyes (52%) achieved a visual acuity of 20/50 or better and only six eyes (14%) achieved a visual acuity of 20/25 or better. In only five eyes was the final visual acuity in the operated-on eye more than two lines better than the final visual acuity in the fellow eye.(ABSTRACT TRUNCATED AT 250 WORDS)     

Precarved lyophilized tissue for lamellar keratoplasty in recurrent pterygium

Thirteen eyes with recurrent pterygia were treated with excision and lamellar keratoplasty using precarved, lyophilized donor cornea. After an average follow-up of 23 months, only one eye (7.7%) required repeat excision. Two eyes (15.4%) had minor recurrences that were asymptomatic and did not progress. Minimal vascularization at the interface between donor and recipient cornea was frequent, but this completely regressed after suture removal and topical corticosteroid treatment. Limitation of movement, when present preoperatively, was improved or eliminated. Best corrected visual acuity was unchanged in eight eyes (61.5%), decreased by one line in two eyes (15.4%), and improved by one or two lines in three eyes (23.1%). Postoperative astigmatism was within 0.5 diopter of the preoperative value in 11 eyes (84.6%); one eye (7.7%) had a postoperative increase of 1 diopter and another eye (7.7%) of 2 diopters.     

Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment

objective: To examine the results of pars plana vitrectomy for nonclearing vitreous opacities associated with ocular sarcoidosis that is resistant to corticosteroid treatment. Methods: Eight consecutive patients (11 eyes) with vitreous opacities and uveitis associated with sarcoidosis were studied. All patients were resistant to or intolerant of corticosteroid therapy. All eyes underwent pars plana vitrectomy, followed by evaluation of visual acuity and recording of the grade of inflammation and complications. Results: Seven eyes had gained two or more lines of Snellen visual acuity six months postoperatively; visual acuity remained unchanged in the other four eyes. Vitreous inflammation was reduced in all cases. Severe postoperative inflammation did not recur in any eyes. Five eyes developed visually significant cataracts and underwent cataract extraction and intraocular lens insertion within 8–30 months. Based on slit-lamp biomicroscopy and fluorescein angiography, preoperative cystoid macular edema in five eyes resolved or improved within six months after vitrectomy. Postoperative complications included elevated intraocular pressure in three eyes, cataract formation in six eyes, epiretinal membrane formation in one eye, and choroidal neovascularization in one eye. None of the patients developed cystoid macular edema postoperatively. Only three patients received systemic corticosteroids after surgery. At the final visit, only one patient required systemic corticosteroid therapy. Conclusions: Pars plana vitrectomy appears to have beneficial effects on restoring vision, stabilizing vitreous inflammation, and reducing systemic corticosteroid requirements in eyes with thick vitreous opacities associated with sarcoidosis that is resistant to medical treatment.     

Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment

OBJECTIVE: To examine the results of pars plana vitrectomy for nonclearing vitreous opacities associated with ocular sarcoidosis that is resistant to corticosteroid treatment. METHODS: Eight consecutive patients (11 eyes) with vitreous opacities and uveitis associated with sarcoidosis were studied. All patients were resistant to or intolerant of corticosteroid therapy. All eyes underwent pars plana vitrectomy, followed by evaluation of visual acuity and recording of the grade of inflammation and complications. RESULTS: Seven eyes had gained two or more lines of Snellen visual acuity six months postoperatively; visual acuity remained unchanged in the other four eyes. Vitreous inflammation was reduced in all cases. Severe postoperative inflammation did not recur in any eyes. Five eyes developed visually significant cataracts and underwent cataract extraction and intraocular lens insertion within 8-30 months. Based on slit-lamp biomicroscopy and fluorescein angiography, preoperative cystoid macular edema in five eyes resolved or improved within six months after vitrectomy. Postoperative complications included elevated intraocular pressure in three eyes, cataract formation in six eyes, epiretinal membrane formation in one eye, and choroidal neovascularization in one eye. None of the patients developed cystoid macular edema postoperatively. Only three patients received systemic corticosteroids after surgery. At the final visit, only one patient required systemic corticosteroid therapy. CONCLUSIONS: Pars plana vitrectomy appears to have beneficial effects on restoring vision, stabilizing vitreous inflammation, and reducing systemic corticosteroid requirements in eyes with thick vitreous opacities associated with sarcoidosis that is resistant to medical treatment.     

Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography

Idiopathic central serous chorioretinopathy (ICSC) is typically described as a self-limited, unilateral disease that affects healthy, young adult males. The authors studied 13 patients (14 eyes) who had documented spontaneous resolution of symptomatic macular detachments. These patients were evaluated in a longitudinal fashion to determine the fate of the retinal pigment epithelium (RPE) as viewed angiographically, both in the initially affected eyes and the fellow eyes. At the time of follow-up examination of the initially affected eyes, nonleaking RPE defects had developed inside the areas of previous serous detachment in all cases. Nonleaking RPE defects had developed outside these areas in six (43%) eyes. Two (14%) eyes had new, asymptomatic macular detachments. Six (42%) fellow eyes had new RPE window defects; two (17%) of them also had active RPE dye leakage resulting in asymptomatic macular detachment at the final examination. Four (29%) originally involved eyes and one (8%) fellow eye lost more than two lines of Snellen visual acuity during the follow-up period. The authors' results suggest that ICSC may be a progressive bilateral disease that develops asymmetrically and causes diffuse RPE changes not localized to the area of serous detachment. Long-term follow-up of these patients may, therefore, be advisable.     

白内障超声乳化治疗葡萄膜炎并发白内障临床分析

目的：探讨白内障超声乳化治疗葡萄膜炎并发白内障的临床效果。方法：对20例20眼葡萄膜炎并发白内障患者行白内障超声乳化摘除及人工晶状体植入术,其中3眼联合周边虹膜切除术。结果：术后2wk18眼（90%）视力较前提高。术后2wk矫正视力〉0.5者10眼（50%）,0.3～0.5者5眼（25%）,0.1～0.2者2眼（10%）,〈0.1者1眼（5%）,视力无变化者2眼（10%）。结论：超声乳化治疗葡萄膜炎并发白内障,虽然手术较复杂,但整体效果良好。     

Photodynamic therapy of AMD for the first (better sight) and the second (worse sight) eyes

BACKGROUND: Photodynamic therapy (PDT) is the standard treatment procedure for many forms of exudative and/or neovascular AMD. Despite therapy, visual acuity often drops to low vision levels. The cost efficiency of treating the eye in which vision is worse is therefore the subject of some controversy. PATIENTS AND METHODS: A retrospective case-control study was conducted in all patients who were treated with PDT at the Universit?tsspital Zürich between September 1999 and November 2004. Each patient's first (with worse vision) and second (with better vision) eyes were compared for situation on presentation and course during treatment. RESULTS: In 117/228 cases (51.3%) visual acuity of the treated eye was better than (or identical to) that of the fellow eye at presentation. Visual acuity before therapy was an average of 0.58+/-0.27 logMAR [Snellen: 0.26 (0.14-0.49)] in the eyes with better visual acuity and 0.69+/-0.4 logMAR [Snellen 0.20 (0.08-0.51)] in the fellow eyes (p=0.015). After therapy there was no significant difference between the patient groups in visual acuity or in the magnitude of any change in visual acuity, or in lesion size or change in lesion size. CONCLUSION: The outcome of PDT of a second eye (with better visual acuity) is not significantly better than the result obtained in the first eye (the one with worse visual acuity initially).     

High incidence of cataract formation after implantation of a silicone posterior chamber lens in phakic, highly myopic eyes.

OBJECTIVE: To assess the effectiveness and safety of implantation of a negative, silicone, posterior chamber intraocular lens (IOL) in the ciliary sulcus of phakic, highly myopic eyes. DESIGN: Noncomparative consecutive interventional series. PARTICIPANTS: Eighteen eyes of 10 patients suffering from high-degree myopia (spherical equivalent < -10 diopters) undergoing implantation of a Fyodorov 094M-1 IOL by the same surgeon (P.H.B.) were evaluated. INTERVENTION: A standard surgical technique was used in all patients under peribulbar anesthesia. The IOL was implanted in the ciliary sulcus immediately in front of the natural lens under protection of a viscoelastic substance (Healon) through a 3.5-mm temporal or nasal clear-corneal tunnel. No sutures were necessary in any case. A peripheral iridectomy was performed intraoperatively in 14 eyes, whereas 4 additional eyes received a yttrium-aluminum-garnet peripheral iridectomy after surgery. At the end of surgery, gentamicin and dexamethasone were given both topically and subconjunctivally. MAIN OUTCOME MEASURES: Visual acuity and refraction were measured before surgery, as well as 1 day, 3 months, 6 months, and 2 years after surgery. Postoperative complications were recorded. RESULTS: Best-corrected visual acuity remained unchanged (1 eye) or improved (6 eyes by 1, 5 eyes by 2, and 2 eyes by 3 Snellen lines, respectively) in 14 of 17 eyes, whereas 3 eyes experienced a decrease in best-corrected visual acuity by 1 Snellen line. Postoperative refraction approached the desired slight undercorrection at all times of examination. Cataract formation of the anterior subcapsular (8 eyes) or nuclear (only 1 eye) type was observed in overall 9 (52.9%) of 17 eyes. When considering only the patients with a follow-up of 2 years, the incidence of cataract formation was 81.9% (9 of 11 eyes). CONCLUSIONS: The high incidence of cataract formation should discourage the implantation of the type of IOL used in this study in phakic eyes to correct high-degree myopia.     

Lysis of vitreous strands with neodymium: YAG laser

Eighteen eyes with vitreous strands adherent to the corneoscleral wounds of previous cataract surgery were treated with neodymium: YAG laser to lyse those strands. Twelve eyes were treated for management of cystoid macular edema (CME group); six eyes were treated for prophylaxis of possible CME (prophylactic group). In the CME group, visual acuity improved two or more lines in nine eyes (75.0%), and seven eyes had a post laser visual acuity of 0.5 or better (One eye had a pre-treatment visual acuity of 0.5 or better). In the prophylactic group, visual acuity was either maintained at the pre-treatment visual acuity of 0.5 or better. In the prophylactic group, visual acuity was either maintained at the pre-treatment level or improved in five eyes (83.3%) 18 months later following laser treatment. This procedure was complicated by retinal detachment in one case and the elevation of intraocular pressure over 10 mmHg in another case.     

Pediatric rhegmatogenous retinal detachment

PURPOSE: To review the clinical features and surgical and visual outcomes of pediatric rhegmatogenous retinal detachment (RRD) as seen in a tertiary referral center. METHODS: Retrospective case series spanning 6 years from January 1, 1991 to January 1, 1997. Exclusionary criteria were trauma disrupting the globe and acute retinopathy of prematurity. RESULTS: The authors reviewed a series of 29 eyes in 27 pediatric patients (birth to 18 years of age) with RRD. Seventy percent of the patients were male. The mean patient age was 9.6 years. Bilateral RRD was present in 22% of patients; 89% of patients had some form of bilateral ocular pathology at initial presentation. The two most common etiologies (34% each) were myopia and eyes that had undergone surgery for another ocular disorder with subsequent development of RRD. The most common presentation was decreased vision, with a mean duration of 52 days. At presentation, 75% of the affected eyes and 48% of the fellow eyes had visual acuity worse than 20/800. The most common type of retinal break was a horseshoe tear. Late diagnosis was a common problem, evidenced by the frequency of macular detachment (79%) and proliferative vitreoretinopathy (45%) at initial presentation. The most common primary repair was a scleral buckle. Anatomic reattachment was ultimately accomplished in 72% of cases with a mean of 2.2 surgeries per eye. Average postoperative follow-up time was 21.4 months (range 4 to 61 months). At final follow-up, 41% of the affected eyes had visual acuity 20/800 or better. Thirty-eight percent of the affected eyes had a final visual acuity better than or equal to the fellow eye. CONCLUSION: In this series, pediatric RRD occurred most commonly in association with myopia (Stickler's syndrome and adolescent retinopathy of prematurity) and prior intraocular surgery. Most eyes were anatomically reattached after multiple surgeries. Forty-one percent of eyes retained vision of 20/800 or better. Preserving vision in children with RRD is of great importance, particularly given the 89% frequency of vision-threatening abnormalities in fellow eyes.     

The gradient filter test to assess amblyopia

A new technique, the gradient filter test, was developed for evaluating changes in the visual acuity of preverbal children undergoing treatment for amblyopia. The gradient filter test consists of a series of calibrated photographic fog filter and prism lenses. The combined prism-filter lenses are placed in front of the normal fixing eye. The greatest density (fogging value) filter that causes a switch in fixation from the amblyopic to the normal eye is noted. In both normal eyes of 20 nonamblyopic patients and the fellow (non-amblyopic) eyes of 20 amblyopic patients, visual acuity decreased as the density of the prism-filter lens increased. The gradient filter test accurately detected an improvement in visual acuity when compared with optotype measurements in eight patients undergoing occlusion therapy. The gradient filter test is a useful clinical tool that can assess changes in visual acuity in preverbal children who are being treated for amblyopia.     

Prophylactic perifoveal laser treatment of soft drusen

Purpose: To assess the efficacy and safety of perifoveal laser to cause drusen to resorb, and establish a treatment protocol.
Methods: Treatment technique was determined by the outcome in one patient with 15-year follow-up. In an uncontrolled series a perifoveal ring of gentle laser was applied to 30 eyes of 28 patients, 18 with bilateral drusen and 10 with exudative disease in the fellow eye. Comparison was made between treated and untreated eyes in 14 patients with bilateral drusen. Mean follow-up was 16.8 months (range, three to 42 months).
Results: Soft drusen resorbed in all treated eyes in the vicinity of laser and within the fovea. Large soft confluent drusen (>500 μm) responded most rapidly. Visual acuity improved one or more lines in 12 (40%) treated eyes, was unchanged in 16 (53%) and deteriorated in two (7%). In 14 patients with bilateral drusen in whom only one eye was treated, VA remained unchanged in 10 eyes and improved in four treated eyes while none of the untreated eyes improved (P= 0.03, χ²) and decreased in four eyes. Atrophic expansion of laser burns was minimal. CNV developed in two of 30 eyes (7%).
Conclusion: Perifoveal laser treatment appears to expedite the regression of soft drusen within the fovea. The risks of complications may be reduced by treating eyes early, before pigment changes develop and by applying a minimum number of burns at a distance greater than 750 μ m from the foveal centre. Treatment should currently be administered only in the context of a prospective clinical trial, which is required to assess whether this treatment results in lowered risk of visual loss from CNV or geographic atrophy.     

渗出型老年性黄斑变性重复光动力疗法的临床观察

目的 总结2002年7月至2005年3月光动力疗法（PDT）治疗渗出型老年黄斑变性（AMD），重复治疗病例的疗效和临床特点。 方法 回顾分析渗出型AMD患者78例94只眼采用PDT治疗，患者平均年龄68.4岁,治疗次数为132次，平均1.4次,其中22例30只眼接受重复PDT治疗,占治疗总数31.9%。30只眼共进行PDT治疗68次，其中2次22只眼，占73.3%；3次7只眼，占23.3%；6次1只眼，占3.3%。随诊时间3~32个月,平均随诊时间16.7个月。 结果 PDT治疗后末次随诊检查时，荧光素眼底血管造影(FFA)或FFA联合吲哚青绿血管造影(ICGA)检查显示CNV渗漏停止14只眼，占46.7%；渗漏减少12只眼，占40%；持续渗漏4只眼，占13.3%。与首次PDT治疗前相比，末次检查矫正视力提高≥2行7只眼，占23.3%；视力波动在上下1行以内14只眼，占43.3%；视力下降≥2行9只眼，占30%。首次PDT后最佳矫正视力13只眼视力提高≥2行，占43.3%；12只眼视力波动在上下1行之内，占40%；5只眼视力下降≥2行，占16.7%。在随诊期中，最佳矫正视力出现在首次PDT后24只眼，占80%；有5只眼出现在2次PDT后，占16.7%；1只眼出现在3次PDT后，占3.3%。 结论 在重复PDT治疗患者中，末次随诊检查大部分眼CNV能完全或部分闭合，视力提高和维持者占67.8%，最佳矫正视力多出现在首次PDT后,随着PDT治疗次数的增加，最佳矫正视力出现的概率减小。 (中华眼底病杂志, 2006, 22: 220-223)     

Excimer laser refractive keratectomy for high myopia. 6-month follow-up of patients treated bilaterally.

Both eyes of twenty patients were treated for myopia with refractive keratectomy using an excimer laser (193 nm), and followed for six months. The 40 eyes were divided into Group I (22 eyes) with an attempted refraction change of 5-8 diopters; and Group I (18 eyes) with 9-12 diopters of attempted refraction change. In Group I the corrected visual acuity improved or was unchanged in 16/22 eyes. Two eyes with high preoperative corrected visual acuity had experienced a significant loss in corrected visual acuity after 6 months. In Group II, the corrected visual acuity decreased in 10/18 eyes, in 4 eyes significantly. Among the 40 eyes, 39 had a refraction change less than intended after 6 months. Overcorrection was seen in only 1 eye. In Group I, 20/22 eyes were corrected up to 2.5 diopters less than attempted. In Group II, 9/18 eyes were more than 2.5 diopters from the attempted correction. All eyes developed subepithelial opacification ('haze'), which, in spite of steroid treatment, was still present after 6 months. The haze was more severe in eyes treated with 9-12 diopters of attempted refraction change. The achieved refraction change in the two eyes of the same patient was found to be correlated, possibly due to an individual factor in corneal wound healing.     

YAG激光虹膜周切术治疗药物难控制性急性闭角型青光眼

目的:探讨YAG激光周边虹膜切除术在药物难控制急性闭角型青光眼治疗中的作用。方法:回顾分析我院住院患者共124例124眼,其中男51例,女73例,入院诊断符合急性闭角型青光眼发作期临床特征,且药物治疗24h后眼压仍>21mmHg的急性闭角型青光眼患者,其中控制眼压为21~35mmHg者51眼(41.1%),眼压36~50mmHg者37眼(29.8%),50mmHg以上者36眼(29.1%)。视力范围为光感~0.3。所有患者均在表面麻醉下行YAG激光周边虹膜切除术治疗,术后继续观察眼压、视力、前房深度变化,眼压控制稳定后分别进行小梁切除术、青光眼白内障联合人工晶状体植入术,或单纯白内障超声乳化吸出联合人工晶状体植入术。结果:患者124例124眼急性闭角性青光眼患者行YAG激光虹膜周切术后,第2d检测眼压≤21mmHg者28眼(22.6%),眼压为22~35mmHg者60眼(48.4%),眼压36~50mmHg者25眼(20.2%),眼压>50mmHg者11眼(8.9%);激光术后视力增加3行者33眼（26.6%）,2行者31眼(25.0%),视力增加1行者44眼(35.5%),视力不增加者16眼(12.9%);119眼前房深度增加(96.0%); YAG激光虹膜周切术后并发前房出血98眼(79.0%)。眼压控制稳定后分别进行小梁切除术37眼,青光眼白内障联合人工晶状体植入术43眼,白内障超声乳化吸出联合人工晶状体植入术44眼。观察随访3~9mo,眼压控制≤18mmHg者95眼,眼压≤25mmHg者24眼,眼压为26~35mmHg者5眼,未见前房积血、黄斑囊样水肿等并发症。结论:YAG激光虹膜周切术在药物难控制性急性闭角型青光眼治疗中能明显降低眼压,为各种青光眼手术的治疗提供安全可靠的条件,有助于视功能保护和恢复,提高疗效。     

Neodymium: YAG laser vitreolysis for treatment and prophylaxis of cystoid macular oedema

Eighteen eyes with vitreous strands adherent to the corneoscleral wound of previous cataract surgery were treated with neodymium: YAG laser to achieve vitreolysis. Twelve eyes were treated for management of cystoid macular oedema (CMO group) and six eyes were treated for prophylaxis of possible CMO (prophylactic group). In the CMO group, visual acuity improved two or more Snellen lines in 10 eyes (83.3%) and seven eyes had a post–laser visual acuity of 20/40 or better (one eye had a pre–treatment visual acuity of 20/40 or better). In the prophylactic group, visual acuity was either maintained at the pre–treatment level or improved in five eyes (83.3%) eighteen months after laser treatment. This procedure was complicated by retinal detachment in one case and elevation of intraocular pressure over 10 mmHg in another case.